Prebiotic consumption and the incidence of overweight in a Mediterranean cohort: The Seguimiento Universidad de Navarra Project

American Journal of Clinical Nutrition

Volumn 102, Issue 6, 2015, Pages 1554-1562

  Perez Cornago, Aurora ^a   Martinez Gonzalez, Miguel A ^a,b,c   Ruiz Canela, Miguel ^a,b,c   Jaurrieta, Ignacio ^a   Carlos, Silvia ^a,b,c   Sayon Orea, Carmen ^a,b,c   Bes Rastrollo, Maira ^a,b,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Recinto de Complejo Hospitalario de Navarra   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

Fructans; Galacto oligosaccharides; GOS; Obesity; Overweight; Prebiotics; Prospective; SUN cohort

Indexed keywords

FRUCTAN; GALACTOSE OLIGOSACCHARIDE; PREBIOTIC AGENT; OLIGOGALACTURONIC ACID; OLIGOSACCHARIDE;

ADULT; ARTICLE; ASPARAGUS; BANANA; BODY MASS; BODY WEIGHT; BREAD; DIABETES MELLITUS; DIETARY FIBER; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; GRADUATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MIDDLE AGED; NEOPLASM; OBESITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SOUTHERN EUROPE; WHITE BREAD; WHOLE GRAIN BREAD; COHORT ANALYSIS; EDUCATIONAL STATUS; FOLLOW UP; LONGITUDINAL STUDY; OVERWEIGHT; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODEL; SELF REPORT; SPAIN;

ADULT; BODY MASS INDEX; COHORT STUDIES; DIET, MEDITERRANEAN; EDUCATIONAL STATUS; FEMALE; FRUCTANS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; LOST TO FOLLOW-UP; MALE; OLIGOSACCHARIDES; OVERWEIGHT; PATIENT COMPLIANCE; PREBIOTICS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SELF REPORT; SPAIN;

EID: 84948766410     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.121202     Document Type: Article

References (36)

1. Tchernof A, Despres JP. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013;93:359-404
2. Ibero-Baraibar I, Abete I, Navas-Carretero S, Massis-Zaid A, Martinez JA, Zulet MA. Oxidised LDL levels decreases after the consumption of ready-to-eat meals supplemented with cocoa extract within a hypocaloric diet. Nutrition, metabolism, and cardiovascular diseases. Nutr Metab Cardiovasc Dis 2014;24:416-22
3. Abete I, Perez-Cornago A, Navas-Carretero S, Bondia-Pons I, Zulet MA, Martinez JA. A regular lycopene enriched tomato sauce consumption influences antioxidant status of healthy young-subjects: A crossover study. J Funct Foods 2013;5:28-35
4. Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients 2013;5:1417-35
5. Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis 2015;60 (Suppl 2):S108-21
6. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 2011;7:639-46
7. Dash S, Clarke G, Berk M, Jacka FN. The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry 2015;28: 1-6
8. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004;17:259-75
9. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 2010;104(Suppl 2): S1-63
10. Bruno-Barcena JM, Azcarate-Peril MA. Galacto-oligosaccharides and colorectal cancer: feeding our intestinal probiome. J Funct Foods 2015; 12:92-108
11. Schaafsma G, Slavin JL. Significance of inulin fructans in the human diet. Compr Rev Food Sci F 2015;14:37-47
12. Graham C, Mullen A, Whelan K. Obesity and the gastrointestinal microbiota: a review of associations and mechanisms. Nutr Rev 2015; 73:376-85
13. Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 2013;143:324-31
14. Balcázar-Muñoz BR, Martinez-Abundis E, Gonzalez-Ortiz M. Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia. Rev Med Chil 2003;131:597-604
15. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009;90:1236-43
16. Seguí-Gómez M, de la Fuente C, Vazquez Z, de Irala J, Martinez-Gonzalez MA. Cohort profile: the 'Seguimiento Universidad de Navarra' (SUN) study. Int J Epidemiol 2006;35:1417-22
17. Willett WC. Nutritional epidemiology. 3rd ed. New York: Oxford University Press, 2013
18. Fuente-Arrillaga C, Ruiz ZV, Bes-Rastrollo M, Sampson L, Martinez-Gonzalez MA. Reproducibility of an FFQ validated in Spain. Public Health Nutr 2010;13:1364-72
19. Muir JG, Shepherd SJ, Rosella O, Rose R, Barrett JS, Gibson PR. Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem 2007;55:6619-27
20. Biesiekierski JR, Rosella O, Rose R, Liels K, Barrett JS, Shepherd SJ, Gibson PR, Muir JG. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet 2011;24:154-76
21. Peshev D, Van den Ende W. Fructans: prebiotics and immunomodulators. J Funct Foods 2014;8:348-57
22. Muir JG, Rose R, Rosella O, Liels K, Barrett JS, Shepherd SJ, Gibson PR. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem 2009;57:554-65
23. Bes-Rastrollo M, Pérez Valdivieso JR, Sánchez-Villegas A, Alonso A, Martinez-Gonzalez MA. Validation of self-reported weight and body mass index in the participants of a cohort of university graduates. Rev Esp Obes 2005;3:183-9
24. Martínez-González MA, Lopez-Fontana C, Varo JJ, Sanchez-Villegas A, Martinez JA. Validation of the Spanish version of the physical activity questionnaire used in the Nurses' Health Study and the Health Professionals' Follow-up Study. Public Health Nutr 2005;8: 920-7
25. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003;348:2599-608
26. Slavin JL. Dietary fiber and body weight. Nutrition 2005;21:411-8
27. Zhong Y, Marungruang N, Fak F, Nyman M. Effects of two wholegrain barley varieties on caecal SCFA, gut microbiota and plasma inflammatory markers in rats consuming low-and high-fat diets. Br J Nutr 2015;113:1558-70
28. Hur KY, Lee MS. gut microbiota and metabolic disorders. Diabetes Metab J 2015;39:198-203
29. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 2010; 1801:1175-83
30. West CE, Renz H, Jenmalm MC, Kozyrskyj AL, Allen KJ, Vuillermin P, Prescott SL. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol 2015;135:3-13, quiz 4
31. Leonel AJ, Alvarez-Leite JI. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care 2012;15:474-9
32. Tedelind S, Westberg F, Kjerrulf M, Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007;13:2826-32
33. Zimmer J, Lange B, Frick JS, Sauer H, Zimmermann K, Schwiertz A, Rusch K, Klosterhalfen S, Enck P. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 2012;66:53-60
34. Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009;89:1751-9
35. Jakobsdottir G, Xu J, Molin G, Ahrne S, Nyman M. High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS One 2013;8
36. Martinez-Gonzalez MA, Sayon-Orea C, Ruiz-Canela M, de la Fuente C, Gea A, Bes-Rastrollo M. Yogurt consumption, weight change and risk of overweight/obesity: the SUN cohort study. Nutr Metab Cardiovasc Dis 2014;24:1189-96